Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction

Simple item page
dc.contributor.authorDoshi, Sanjay Lalitchandra
dc.date.accessioned2017-09-24T06:41:59Z
dc.date.available2017-09-24T06:41:59Z
dc.date.issued2001
dc.description.abstractErectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/4677
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan Universiti Sains Malaysiaen_US
dc.subjectInternal Medicineen_US
dc.subjectIntracavernosal Alprostadilen_US
dc.titleEfficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunctionen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pusat Pengajian Sains Perubatan - Tesis